Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immune Modulation Therapy for ERT-naïve or ERT-treated Pompe Disease Patients

NCT02525172 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.

NCT NCT02525172
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02525172 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immune Modulation Therapy for ERT-naïve or ERT-treated Pompe Disease Patients
Lead sponsor
National Taiwan University Hospital
Phase
Phase 4
Overall status
Unknown status
Start date
August 31, 2015
Completion date
July 31, 2020
Enrollment
8 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pompe disease